William Pollack

Source: Wikipedia, the free encyclopedia.

William Pollack (February 26, 1926 – November 3, 2013) was a

developed countries.[1] Prior to the RhoGAM vaccine, Rh disease was responsible for approximately 10,000 infant deaths in the United States annually.[3]

The development of the RhoGAM vaccine has been called one of the ten greatest medical breakthroughs of the 20th Century.

Early life and education

Pollack was born in

St. George's Hospital Medical School.[1] He then worked in the pathology department at St. George's from 1948 to 1954.[1]

Career

Pollack moved to British Columbia, Canada, in 1954 to become a director of a blood bank and clinical laboratory.[1] In 1956, he moved, this time to Princeton, New Jersey. He joined the staff of Ortho Pharmaceutical, where he began his research on his Rh disease vaccine.[1] He would eventually become Ortho Pharmaceutical's vice president and director of research.[1] Pollack obtained a doctorate in zoology at Rutgers University while researching Rh disease at Ortho.[1]

Pollack later taught immunology at Rutgers University and Columbia University.[3]

Illness and death

Dr. William Pollack died from complications of

heart disease on November 3, 2013, in Yorba Linda, California, at the age of 87.[1] He was survived by his sons, Malcolm and David, and predeceased by his wife, Alison Calder, who died in 2006.[1]

References

  1. ^ a b c d e f g h i j k l m n o Maugh II, Thomas H. (2013-11-17). "William Pollack dies at 87; helped conquer deadly Rh disease". Los Angeles Times. Retrieved 2013-12-02.
  2. ^ "William Pollack - Obituary". The Daily Telegraph. 2013-11-25. Retrieved 2013-12-02.
  3. ^
    New York Times
    . Retrieved 2013-12-02.